2005 Indian Biotech Industry

http://www.chinaccm.com 2005-10-22 11:34

Published:                October 2005
Price (USD):             $1,500 /single user PDF licence

Report Summary

India being on the "threshold of biotech revolution" has 280 biotech and 180 bio suppliers contributing to the total biotech market worth US $100 billion. The country has a global market worth $91 billion and there is scope for cheap R&D through bio-partnering and co-developing technologies mainly with Chinese and American companies. Already the world pharma companies are seeking India to set their research and development centers here. Moreover, to facilitate foreign investment, capital and government policies are being revised.

It has been found that Indian biotech firms are making a strong position, developing business models and improving product commercialization capabilities. With this, India could make a good $5 billion by 2010.

A new market research report, "Indian Biotech Industry (2005)"  provides insights into the Indian biotech industry including product estimates, market segmentation, and regulatory mechanisms, pricing policies, patents and opportunities in international venture ship. The report says how in 2004-05, 20 privately helped drug discovery groups have started to operate in India with their business primarily to create innovations and IPR. The biotech industry is likely to draw huge FDI to the Union Government.

The market research report also details the success of the biotech firms in terms of their business profiles, export outlets, financial performances and future plans. It also has the contact details of the major industry associations.

Report Highlights

- Assessment of what is happening in China across the value chain, the organizational structure and, the interaction between Indo-China biotech businesses and research.
- Changes in patent policies & Intellectual Property Rights - A strategic analysis
- Sales and demand analysis for biotech products in agri-business and clinical studies, 2005-2010.
- An estimate of the recent and future investment programs in Indian biotechnology sector and its growth statistics.
- SWOT analysis of Indian biotechnology sector.
- New drafts and policies formulated by the National Biotechnology Development Authorities and how it facilitates in private-public - partnerships across biotech firms.
- Key profiles & marketing strategies.

Report Features

The market research report "Indian Biotech Industry (2005)" prepared gives a detail analysis of the Indian biotech market scenario, the technological developments and researches. These have been divided into a number of relevant chapters. Chapter 1 giving an introduction is followed by chapter 2 which talks about the changing legal framework of the biotech sector in India mentioning, fiscal incentives, changes in patents acts, plant varieties and Farmers’ Rights Protection Act, 2001 and other regulations for the biotech sector. Chapter 3 gives the state driven initiatives and policies, region wise.

Chapter 4 analyzes the Indian biotechnology market for 2005 in terms of size, demand, industry segments, exports, number of companies & associations, employment opportunities, investments and status of biotech parks. Chapter 5 gives the SWOT analysis whereas the chapter 6 discuss about the Indian Biotechnology Industries and outsourcing opportunities. Chapter 7, 8 and 9 talk about R&D strengths, India's New Draft National Biotechnology Development strategy and the key industry trends and opportunities in biotech industry. Chapter 10 and 11 covers strategies for the industry's future and financial strategy for emerging bio-companies. Finally, chapter 12 gives the company profiles of key players.

Report Outline

Chapter 1    Biotechnology in India - An Introduction

Chapter 2    Biotech Sector in India:  Changing Legal Framework

2.1    Fiscal Incentives provided to the Biotech Sector
2.2    Important Changes to the Patents Act Proposed in the Third Amendment Bill
2.3    Plant Varieties and Farmers’ Rights Protection Act, 2001
2.4    Other Regulations Impacting the Biotech Sector
    2.4.1  Licensing
    2.4.2  Clinical Trials
    2.4.3  Seeds Act and Policy
    2.4.4  Environmental Clearances
    2.4.5  Biodiversity
2.5    Status on Enforcement

Chapter 3    Bio-Clusters:  State Driven Initiatives and Policies

3.1    Southern Region
3.2    Western Region
3.3    Northern Region

Chapter 4    Indian Biotechnology Market Analysis, 2005

4.1    Total Market Size, (%) 2005
4.2    Growth Forecasts for the Indian Biotechnology Industry ($ Million), 2007-2010
4.3    Market Size by Industry Segments (%), 2005
    4.3.1  Biopharmaceuticals
    4.3.2  Bioinformatics
    4.3.3  Industrial Biotech
    4.3.4  Agri Biotech
    4.3.5  Bioservices (Contract Research)
    4.3.6  Employment in Indian Biotech Industry, (%)
4.4    Biotech Exports, by Segment-wise (%), 2005
4.4.1 Biotech Suppliers
4.5    Number of Companies and Associations (in numbers), 2005
4.6    Employment Opportunities in India
4.7    Investments in Indian Biotechnology Sector, 2005
4.8    Status of Biotech Parks in India

Chapter 5    SWOT Analysis of Indian Biotechnology Sector

Chapter 6    India Biotechnology Industry and Outsourcing Opportunities

Chapter 7    India's Biotechnology Research and Development Strengths

Chapter 8    India's New Draft National Biotechnology Development Strategy - Geared Towards Encouraging Public-Private Partnership

Chapter 9    Key Industry Trends and Opportunities in Indian Biotech Industry

Chapter 10    Strategies for the Indian Biotech Industry Future

10.1    Generate National Level Resource Strength in Bioinformatics
10.2    Promote R&D Strengths
10.3    Promote Entrepreneurial Development
10.4    Globalization of the National Bioinformatics Initiatives
10.5    Encourage Human Resource Development, Education, & Awareness
10.6    Restructuring of the BTIS Organization for Optimized Performance

Chapter 11    Financial Strategy for Emerging Bio-Companies

Chapter 12    Company Profiles of Key Players

12.1    Biocon
12.2    Serum Institute of India
12.3    Panacea Biotech
12.4    Nicholas Piramal
12.5    Wockhardt Limited
12.6    GlaxoSmithKline
12.7    Bharat Serums
12.8    Krebs Biochemical's & Industries Limited
12.9    Indian Immunologicals
12.10    Zydus Cadila
12.11    Shantha Biotechnics
12.12    Biological E
12.13    Chiron Behring Vaccines
12.14    Eli Lilly and Company
12.15    Novo Nordisk
12.16    Mahyco Monsanto
12.17    Bharat Biotech
12.18    Abbott
12.19    Ranbaxy
12.20    Novozymes

Tables

Table 4-1:  Permitted BT Cotton Seeds
Table 4-2:  Top 20 Biotech Companies in World (2004 & 2005)
Table 4-3:  Top 20 Biotech Companies in India (2004 & 2005)

Figures

Figure 1-1:  Budgetary Allocation of Major Funding Agencies in India (1990-91 & 2000-01)
Figure 4-1:  Indian Biotechnology Industry Revenue Growth ($ Million), 2003 & 2004
Figure 4-2:  Market Size by Industry Segments (%), 2003 & 2004
Figure 4-3:  Percentage Growth in Each Segment
Figure 4-4:  Biotech Industry's Revenue ($ Billion), 2004 & 2010
Figure 4-5:  Percentage of Revenues from BioPharma (2004 & 2005)
Figure 4-6:  Percentage Growth in Market Share
Figure 4-7:  Percentage Market Share by Different Companies in India (2004-2005)
Figure 4-8:  Revenues for Top 5 BioService Players (2004 & 2005)
Figure 4-9:  BioService Market Share in Percentage (2004-2005)
Figure 4-10:  Indian Biotech Industry - Total Manpower (%), 2005
Figure 4-11:  Exports Vs Domestic Business – Percentage Market Share by Each Segment (2004-2005)
Figure 4-12:  Domestic Market - Segment Market Share (%)
Figure 4-13:  Export Market - Segment Market Share (%)
Figure 4-14:  Biotech Suppliers - Percentage Growth (2004-2005)
Figure 4-15:  Top 9 Indian Manufacturers - Turnover (in % growth), 2004-2005
Figure 4-16:  Investments in Indian Biotech Industry (%), 2000-01 to 2004-05